Trials / Conditions / Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
3 registered clinical trials studyying Metastatic Castration Sensitive Prostate Cancer (mCSPC) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enza NCT07028853 | Pfizer | Phase 3 |
| Completed | A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensi NCT07086651 | Pfizer | — |
| Completed | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland NCT05701007 | Pfizer | — |